MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Ovarian cancer diagnosis and treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,301 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,301 works in the cohort · of 4,299,418page 2 of 47

Labels cover 7 of 2,301 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,301 of 2,301 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial
Bradley J. Monk, Nicoletta Colombo, Amit M. Oza, Keiichi Fujiwara, Michael J. Birrer, Leslie M. Randall +12 more
2021· article· en· The Lancet Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
284
citations
afffundno abstractunlabeled
Clinical Trials in Recurrent Ovarian Cancer
Michael Friedländer, Edward L. Trimble, Anna V. Tinker, David S. Alberts, Elisabeth Åvall‐Lundqvist, Mark F. Brady +21 more
2011· review· en· International Journal of Gynecological Cancer· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
231
citations
afffundaboutunlabeled
An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
Martin Köbel, Kurosh Rahimi, Peter Rambau, Christopher Naugler, Cécile Le Page, Liliane Meunier +15 more
2016· article· en· International Journal of Gynecological Pathology· Medicine
distilled prediction:candidate · noneconsensus · none
230
citations
affno abstractunlabeled
Heterogeneity and treatment landscape of ovarian carcinoma
Ana Veneziani, Eduardo González-Ochoa, Husam Alqaisi, Ainhoa Madariaga, Gita Bhat, Marjan Rouzbahman +2 more
2023· review· en· Nature Reviews Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
193
citations
afffundunlabeled
The molecular origin and taxonomy of mucinous ovarian carcinoma
Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland, Prue E. Allan, Kathryn Alsop, Kaushalya Amarasinghe +58 more
2019· article· en· Nature Communications· Medicine
distilled prediction:candidate · noneconsensus · none
187
citations
affunlabeled
Amplification of 11q13 in ovarian carcinoma
Lindsay Brown, Steve E. Kalloger, Melinda A. Miller, Ie‐Ming Shih, Steven E. McKinney, Jennifer L. Santos +5 more
2008· article· en· Genes Chromosomes and Cancer· Medicine
distilled prediction:candidate · noneconsensus · none
183
citations

How this was built: Screen · Findings · About